DE:UR9 Stock Latest News
Company AnnouncementsClinuvel Moves to Enter US$1.3bn ACTH Market with EU Filing for NEURACTHEL3d ago
Company AnnouncementsClinuvel Pharmaceuticals Reports Cessation of Securities in October 6-K Filing2w ago6K
Company AnnouncementsClinuvel Pharmaceuticals Updates U.S. Investors on New and Ceased Securities via Form 6-K3w ago6K
Company AnnouncementsClinuvel Pharmaceuticals Reports Expiry of 61,272 Performance Rights3w ago
Company AnnouncementsClinuvel Seeks ASX Quotation for Additional Ordinary Shares3w ago
Company AnnouncementsClinuvel urges stability ahead of AGM as board warns against potential spill1M agoCompany AnnouncementsClinuvel Shows Sustained Vitiligo Repigmentation with SCENESSE Combo Therapy1M ago
Company AnnouncementsClinuvel Unveils ZEROKIN Single-Use Device for Controlled-Release Drug Delivery1M ago6K
- Company AnnouncementsClinuvel Unveils ZEROKIN Device to Target Growing Self-Injection Market1M ago
Company AnnouncementsVanguard Drops Below Substantial Holder Threshold in Clinuvel Pharmaceuticals2M ago
Company AnnouncementsClinuvel Weighs Nasdaq-Only Listing as Headquarters Shift to U.S.2M ago- Company AnnouncementsClinuvel Flags Key Risks as It Builds U.S.-Led Expansion2M ago
Company AnnouncementsClinuvel Confirms ASX Governance Compliance With 2026 Appendix 4G Filing2M agoCompany AnnouncementsClinuvel Affirms ASX Governance Compliance and Highlights Diversity Gains2M ago
Company AnnouncementsClinuvel Leverages Decade of Profits to Fund U.S. Expansion Despite Flat FY2026 Revenue2M ago
Company AnnouncementsClinuvel Sets Investor Webinar to Unveil 2026 Annual Results2M ago
Company AnnouncementsClinuvel Advances VLRX-L Controlled-Release Injectable Peptide Platform2M ago- Company AnnouncementsClinuvel steps up vitiligo push as SCENESSE data and North American rollout near3M ago
Company AnnouncementsClinuvel maps SCENESSE’s path in vitiligo with new Phase III trial3M ago
